Rimonabant in obese patients with type 2 diabetes
- PMID: 17307090
- DOI: 10.1016/S0140-6736(07)60262-1
Rimonabant in obese patients with type 2 diabetes
Comment on
- 
  
  Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.Lancet. 2006 Nov 11;368(9548):1660-72. doi: 10.1016/S0140-6736(06)69571-8. Lancet. 2006. PMID: 17098084 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
        